Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension

被引：0
|
作者：
Lucas M. Kimmig
Chuanhong Liao
Remzi Bag
机构：
[1] The University of Chicago Medicine,Section of Pulmonary and Critical Care Medicine
[2] The University of Chicago,Department of Public Health Sciences
[3] The University of Chicago,Biological Sciences Division
来源：
Lung | 2020年 / 198卷
关键词：
Pulmonary arterial hypertension; Prostacyclins; Prostanoids; Inhaled prostanoids; Transition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：53 / 58
页数：5
相关论文
共 50 条
  • [1] Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Kimmig, Lucas M.
    Liao, Chuanhong
    Bag, Remzi
    LUNG, 2020, 198 (01) : 53 - 58
  • [2] Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
    Raina, Amresh
    Coons, James C.
    Kanwar, Manreet
    Murali, Srinivas
    Sokos, George
    Benza, Raymond L.
    PULMONARY CIRCULATION, 2013, 3 (01) : 116 - 120
  • [3] Parenteral and Inhaled Prostanoid Therapy in the Treatment of Pulmonary Arterial Hypertension
    McLaughlin, Vallerie V.
    Palevsky, Harold I.
    CLINICS IN CHEST MEDICINE, 2013, 34 (04) : 825 - +
  • [4] Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Bourge, Robert C.
    Tapson, Victor F.
    Safdar, Zeenat
    Benza, Raymond L.
    Channick, Richard N.
    Rosenzweig, Erika B.
    Shapiro, Shelley
    White, Richard James
    McSwain, Christopher Shane
    Gotzkowsky, Stephen Karl
    Nelsen, Andrew C.
    Rubin, Lewis J.
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (01) : 38 - 44
  • [5] Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series
    Enderby, C. Y.
    Soukup, M.
    Al Omari, M.
    Zeiger, T.
    Burger, C.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (05) : 496 - 500
  • [6] Inhaled treprostinil and pulmonary arterial hypertension
    Nadler, Samuel T.
    Edelman, Jeffrey D.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 1115 - 1124
  • [7] Inhaled treprostinil for the treatment of pulmonary arterial hypertension
    LeVarge, Barbara L.
    Channick, Richard N.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2012, 6 (03) : 255 - 265
  • [8] Transitioning from parenteral to inhaled prostacyclin therapy in pulmonary arterial hypertension
    Ataya, Ali
    Somoracki, Angelina
    Cope, Jessica
    Alnuaimat, Hassan
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2016, 40 : 39 - 43
  • [9] Oral treprostinil for the treatment of pulmonary arterial hypertension in patients transitioned from parenteral or inhaled prostacyclins: case series and treatment protocol
    Coons, James C.
    Miller, Taylor
    Simon, Marc A.
    Ishizawar, David C.
    Mathier, Michael A.
    PULMONARY CIRCULATION, 2016, 6 (01) : 132 - 135
  • [10] Transition protocol from subcutaneous treprostinil to intravenous epoprostenol in deteriorating patients with pulmonary arterial hypertension
    Mouratoglou, Sophia Anastasia
    Patsiala, Anthoula
    Feloukidis, Christos
    Karvounis, Haralambos
    Giannakoulas, George
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 306 : 187 - 189
12345